Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Industrials
Cohort
Written by
Cohort |
Case for the defence |
Company outlook |
Aerospace & defence |
4 October 2016 |
Share price performance
Business description
Next events
Analysts
Cohort is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||||
Cohort continues to successfully execute on its strategy of building a specialist defence technical advisory company, with innovative, flexible and specialist subsidiaries able to focus on organic opportunities. Strategic acquisitions such as the recently acquired EID augment growth, and extend reach both technically and geographically. The combination is delivering increasing shareholder returns. Our fair value stands at 439p, implying significant potential for shareholders.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
04/15 |
99.9 |
10.2 |
20.5 |
5.0 |
15.4 |
1.6 |
04/16 |
112.6 |
12.0 |
25.0 |
6.0 |
12.6 |
1.9 |
04/17e |
131.7 |
14.3 |
25.9 |
7.0 |
12.2 |
2.2 |
04/18e |
143.4 |
15.7 |
31.6 |
8.0 |
10.0 |
2.5 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and one-off tax credit of 2.20p in FY16.
Portfolio changes enhance value
The acquisition of EID in Portugal provides a timely expansion into overseas markets. Adding NATO Europe customers as well as new export territories, EID appears well set to continue its recent growth and enhance shareholder returns. The initial 57% holding should increase to 80% before the end of November, further enhancing value. In addition, the outstanding c 50% minority in MCL should be bought in for £5.5m before the year end, removing a significant element of earnings dilution by FY18.
Replenishing the opportunity
One of the most notable features of the current year is expected to be the volume of contract renewals. Order cover for sales in the current year of c 55% was towards the bottom end of the recent range, but we expect this to be topped up substantially in FY17. In addition to major new contract opportunities for SEA, MASS and MCL, around £60m of multi-year product, development, advisory and training orders are expected to renew in FY17. Given the persisting constraints on the UK defence budget this should underpin and validate Cohort’s growth strategy.
Valuation: Significant discount to defence peers
We now calculate fair value as a simple average of a calendar year 2017 peer group based sum-of-the-parts (SOP) and a capped DCF. This currently provides an implied fair value of 439p, compared to 387p previously. That is equivalent to a 9% P/E ratio premium to the UK aerospace and defence peers. We believe this to be warranted as Cohort continues to deliver above-average returns and pursues its growth strategy.
Investment summary
Providing an increasing range of specialist competences
Cohort is a holding company for five autonomous and innovative businesses operating primarily in the defence and security markets, with a UK bias that is slowly being diluted by increased exports and acquisitions. The group executive management provide the strategic and financial guidance that enables the operations to focus on long-term core contracts while retaining the flexibility to address more immediate needs, as well as assist with export pursuits. Subsidiaries also benefit from exchange of ideas and adoption of best practice. The strategy to drive organic growth augmented by selective acquisitions continues to be successfully delivered, with FY16 adjusted operating profit rising by 18%, of which c 28% came from full contributions of prior year acquisitions, J+S and MCL. Adjusted EPS excluding a 2.2p one-off tax credit rose 22% to 24.98p.
The success in acquiring control of EID in late June marks the first overseas acquisition, bringing with it new clients both within NATO Europe and other export territories such as Indonesia and Egypt. While the completion of the transaction was delayed, the value generated during the negotiation period accrued to the benefit of Cohort shareholders, with performance at least matching expectations. EID is expected to account for around 60% of the FY17 revenue growth, and generate low-teens margins. Organic growth looks underpinned by the solid order backlog and the expectation of several long-term contract renewals in the current year.
Portfolio effects should add value
We now base our fair value calculation on an average of a capped DCF forecast and a calendar 2017 based peer group sum-of-the-parts calculation, which currently returns a value of 439p. Management has indicated that it intends to buy in the outstanding MCL minority for £5.5m in the current year, and this is expected to happen by the financial year end. In addition, the purchase of a further stake in EID of 23% for £2.7m is expected to complete by the end of November 2016. We have adjusted our valuations to reflect these changes to debt and minority contributions this year and beyond. The buy-in of the MCL minority would remove a significant element of current earnings dilution. In addition, the favourable tax treatment of R&D credits should enable a subnormal tax rate to be maintained for the time being.
Financials: Reassurance from AGM statement
We feel FY17 expectations remain well supported following the AGM statement. Interim results are due in December. Opening order book cover for sales was 55% (excluding EID), and improved through August to be ahead of the comparable point in FY16. Major contract renewals and opportunities valued at c £60m are expected to convert this year. EID’s initial 10-month contribution feels conservative, with a sales rate comparable to the December 2015 outturn and low-teen margins. Excluding the tax benefit in FY16, we expect adjusted EPS to grow 4% in FY17.
Sensitivities: Still constrained UK defence environment
Notwithstanding the recent acquisition of EID in Portugal, Cohort’s prospects remain dependent on the UK Ministry of Defence (MOD). As a specialist and expert solutions provider, the focus on achieving value for money arising from constrained budgets plays well to Cohort’s strategy. Pace of spending and demand for new solutions is also influenced by operational imperatives. As Cohort seeks to increase export and overseas content this adds new potentials with associated challenges, while introducing an increased element of FX exposure.
Company description: Leveraging defence expertise
Since floating on AIM in 2006, Cohort has been progressively pursuing its strategy of building an independent group in defence technical services, systems and products, both through organic growth and bolt-on acquisitions. A series of acquisitions has seen the company continue to develop, despite pressures on defence budgets since the financial crisis. The group remains a predominantly defence and security company (91% of FY16 sales), but has small positions servicing markets in oil & gas (3%), transport (3%) and other commercial markets (3%, including education).
|
Exhibit 1: Revenue by customer (FY16) |
Exhibit 2: Revenue by capability (FY16) |
|
|
|
Source: Cohort |
Source: Cohort |
|
Exhibit 1: Revenue by customer (FY16) |
|
|
Source: Cohort |
|
Exhibit 2: Revenue by capability (FY16) |
|
|
Source: Cohort |
Focused defence skillsets facilitating growth
Cohort provides a holding company structure for five autonomous subsidiaries, all of which provide specialist capabilities for varying defence and security niches, as shown in Exhibit 3. These capabilities are being extended to commercial opportunities where appropriate, eg ICT and cyber.
|
Exhibit 3: Cohort core capabilities by subsidiary |
|
|
Source: Cohort |
Since 2014, acquisitions plus organic growth have resulted in a trebling of defence product sales to £47m or 42% of group sales (excluding EID). The External Communications Systems (ECS) for UK submarines was a significant element of the organic expansion, with MCL largely a defence products business expanded by the major hearing protection system award in August 2015. EID will likely increase this proportion to around 50% in FY17. Operational support sales have also almost trebled over the least two years and now account for 10% of group sales (£11.3m), boosted by increased export activity for EW and despite some slowdown in offshore support activity for J+S. Training sales have continued to grow, by 32% since 2014, underpinned by on the job and scenario training undertaken by SCS. Studies and analysis saw revenues increase by 46% over the last two years, continuing its upward trend. Application software and secure networks (lower education activity) have been the two main areas of revenue declines over the last two years. Applied research fell last year as the four-year Delivering Dismounted Effect element of the UK’s dismounted soldier programme completed during FY16. Replacement projects are expected from H217. Specialist expertise sales have remained broadly stable in the £10-12m range since 2012 as SCS, MASS and to a lesser extent SEA provide expert individuals to customer teams.
|
Exhibit 4: Cohort revenue development by capability |
|
|
Source: Cohort company reports |
At the year-end Cohort had an order backlog of £116.0m (Exhibit 5) of which £65.3m is deliverable in FY17, £28.8m in FY18 with the remainder extending out to 2023 (Exhibit 6). It should also be noted that order intake during the period was the second highest level since the exceptional intake in FY10. While this was significantly lower than the £134m at the start of the year, Cohort has been working through several major long-term contracts where renewal is expected in the current year. The addition of EID with a significant backlog is indicated to modestly increase the overall level of order cover for FY17.
|
Exhibit 5: Cohort order book development (before EID) |
|
|
Source: Company reports. Note: SEAs space business disposed of in 2014 (order book £10.4m in 2013). |
The order cover indicated by the company at the start of the year, on expected revenues of £120m was 55%. While this was slightly lower than in recent years, the order renewals should boost the FY17 deliverables further as well as topping up the outer years. This is particularly true at SEA where major multi-year contracts signed in the current year and development programmes for the MOD should reverse the consumption of backlog seen in FY16. While the deliverable profiles for MASS and MCL are in better shape than a year ago, these could also be enhanced in FY17. SCS seems likely to remain comparatively flat.
|
Exhibit 6: Cohort order book and associated revenue profile (£m excludes EID) |
|
|
Source: Cohort |
Renewals of more than £60m are expected in the current year. Important additional order opportunities identified by the company for FY17 are
■
Export EWOS work at MASS
■
Sentry aircraft support work for MASS
■
Next phase of the Dismounted Soldier research programme for SEA
■
Support work for Transport for London at SEA
■
Further hearing protection orders at MCL
Combining organic development with focused M&A
The company’s strategy remains unaltered. It continues to offer a variety of specialised engineering, integration and systems knowledge to defence customers. Much of this is through the organic development of core divisions such as MASS and SEA, but management continues to seek acquisitions to further complement this growth. The latest of these, EID in Portugal, extends the strategy to overseas opportunities, in addition to the UK centric purchases that have seen the group develop to its current structure.
The focus on specialist expertise and competences supports innovative and flexible offerings to its customers, and enables the group to maintain healthy returns from what are often niche capabilities, despite some major international competitors.
Divisional outlook
The overall environment for defence expenditure should be improving due to global security and geopolitical concerns although to date, spending levels have remained subdued in the UK. Cohort is positioned to benefit from higher growth spending areas within the UK defence budget such as submarines, electronic warfare and cyber. The group operates through five autonomous subsidiaries, each of which should be able to leverage opportunities that such an improvement should provide. In addition, further expansion to overseas markets should drive incremental top-line growth potential both through direct exports as well as EID in Portugal.
MASS
MASS was founded in 1983 and was acquired by Cohort in August 2006 for £13m. Operating from sites in Lincoln and St Neots, MASS (derivation: mathematical and associated scientific services) provides the core capabilities in Cohort’s electronic warfare (EW) and ICT services offerings. It serves the defence, governmental, education and commercial markets, and includes Cohort’s developing cyber capability. MASS competes against significant defence electronic and cyber security providers including Ultra Electronics, Leonardo, Thales, CGI group, and BAE Systems.
|
Exhibit 7: MASS overview |
|
|
Source: Cohort |
MASS has remained a robust performer within Cohort’s portfolio. Revenues having grown at a 6.4% CAGR over the past five years, generating high-teen margins from a mix of long-term operational support contracts with recurring revenues and increased high margin EW export activity. The Thurbon EW database remains at the core of the activity both in support of Project Shepherd in the UK as well as enabling export customers to build their own analysis capability. MASS is the clear leader in this field supplying the tool, training and operational support. It is also the hub for the development of the group’s rapidly emerging cyber capabilities, as well as the provision of secure networks and IT infrastructure for educational and commercial customers.
A favourable mix of sales in FY16 resulted from lower education activity offset by growth in EW, cyber and strategic systems. This generated a 9% increase in adjusted operating profit from a relatively flat sales performance, a margin of 18.7%. The level of margin is expected to reduce slightly as MASS continues to grow the proportion of business with higher bought in content where margins are lower, notably in the UK, while still growing EW levels both domestically and for export.
MCL
Cohort acquired a controlling 50% plus one share stake in MCL (Marlborough Communications Ltd) for £8.8m in July 2014. Based in Surrey, MCL has been supplying specialised and innovative communications and surveillance technologies to meet C4ISR and ISTAR missions for the UK armed forces since it was founded in 1980. It identifies requirements, designs solutions and/or seeks out available technologies to meet them, and supports advanced electronic and surveillance technologies in operation. It supplies the special forces and intelligence agencies, but technologies are increasingly being adopted by the regular army. The customisation of commercial off the shelf technologies (COTS) differentiates MCL’s business model from other Cohort group businesses. MCL competes against a range of niche systems suppliers, which are often small private ventures.
MCL’s performance has been encouraging with the award of a major hearing protection contract for the British Army opening a new stream of revenues with improved visibility. Order intake of £18m represented a book to bill ratio of 1.31x, with a strong pipeline of opportunities for the current year, notably in hearing protection.
|
Exhibit 8: MCL overview |
|
|
Source: Cohort |
Cohort retains an option to acquire the remaining shares in MCL after September 2016 based on EBIT and order book at that time. This was originally capped at up to £12.5m, but is included in the FY16 accounts with a carrying value of £5.5m. We expect Cohort management to exercise its option before the year end. At present we are assuming no benefit from an early call of the option, but any such move would enhance group earnings due to the minority’s contributions.
SCS
SCS (Systems Consultants Services Ltd) has been part of the group since flotation in March 2006. It provides technical advisory services primarily to defence customers, government agencies and private sector customers, predominantly in the form of expert consultant personnel. SCS competitors include expert advisory companies such as QinetiQ and Atkins, although new entrants are being encouraged by a lack of resource within the MOD to act in the “customer friend” role.
|
Exhibit 9: SCS overview |
|
|
Source: Cohort |
The largest part of its business is the provision of on the job and scenario based training support operations of SCS. The business tends to respond positively to periods of high operational activity for the UK and other armed forces when capability gaps are often identified and require a quick and expert response. However, it is supported by several major long-term contracts. In FY16 the company extended its high level, computer based operational training service contract for the UK’s Joint Warfare Command by a further two years with an option to continue to 2020. To date, Cohort has fulfilled this role for over 15 years. Air Systems provides regulatory and technical assurance and evaluation services to both military and civil authorities.
In FY16 revenues at SCS improved to £18.1m driven by training support work. Margins fell 90bps to 6.9% leaving profits slightly below FY15. This was largely due to unfavourable mix as the prior year was still benefitting from the tail of operational activity in Afghanistan. Despite entering the year with an improved backlog of £11.8m (£9.8m), trading conditions are expected to remain difficult through FY17, as noted in the recent AGM statement, with the Air Systems activity expected to fall.
SEA
SEA (Systems Engineering and Assessment Ltd) was acquired in October 2007 for £25m. SEA operates in four market facing divisions: Maritime, Research & Technical Support, Software Solution & Products, and Subsea Engineering. Across its various activities, SEA competes against major companies such as Thales, QinetiQ, Selex and Babcock.
|
Exhibit 10: SEA overview |
|
|
Source: Cohort |
A key element of SEA’s activity is the supply of the External Communications System (ECS) for Royal Navy submarines. In March the company was awarded a £17m contract by BAE Systems for the supply of its equipment for the second stage of the common ECS (cECS) programme. It covers critical procurement and design into 2017, with follow on orders expected. Ultimately, the cECS will be provided for all Royal Navy submarines. The cECS is expected to reduce system cost, improve operational efficiency and increase the flexibility and sustainability of the fleet. SEA has been supplying its ECS to the Astute programme since 2009, with five boats covered. The initial cECS design contract was awarded to SEA in October 2014. The timing of ECS orders has a significant impact on sales, cash flow and order book, and while the UK programme has peaked in terms of design and engineering sales, domestic deliveries will be augmented by future higher margin export orders including torpedo launchers.
Divisional sales grew by 21% and adjusted operating profit was 35% higher in FY16, largely due to a full contribution from J+S (seven months in FY15). Underlying organic growth was a healthy 6% at the sales level and 32% at the profit level. J+S is now fully integrated which has generated the anticipated annual operational savings of around £0.5m. When acquired J+S brought both defence and offshore energy activity with it, broadening SEA’s capability and offering and extending export territories. Defence products included sonar systems, torpedo launchers and a range of other naval equipment, with subsea engineering capabilities based in Aberdeen.
While the offshore energy segment has proven more challenging than expected at the time of the purchase of J+S in 2014, it has continued to boost SEA’s performance. Offshore energy sales in FY16 actually grew to £3.0m from £2.0m in FY15 despite the oil price weakness.
Transport sales fell slightly in FY16 to £3.5m, despite strong growth of the ROADflow traffic monitoring and enforcement systems. Activity was held back by deferrals from rail customers for the Red Light Systems for level crossings, but these are expected to increase as safety remains a priority issue.
EID
The acquisition of an initial 57% stake in EID was completed on 27 June 2016. A further 23% is expected to be acquired before the end of November on the existing terms, with the Portuguese government expected to retain a minority stake of 20% thereafter. The increase in Cohort’s holding should be modestly earnings enhancing. Andy Thomis and Simon Walther have joined the board.
|
Exhibit 11: EID overview |
|
|
Source: Cohort |
Based near Lisbon with a regional office in Malaysia, EID employs around 140 people. Revenues in calendar 2015 were £15.7m (€18.8m) which exceeded expectations, generating an EBIT of £2.4m (€2.9m) a margin of just over 15%. It was stated on completion to have a positive cash flow, a strong order book and a healthy sales pipeline. It has an experienced management team and a modern manufacturing facility at its main location. EID has been spending around 10% of sales on self-funded R&D to upgrade its technology, notably to IP based communications systems. The last known order book was €35.2m at March 2015, but this is likely to have fallen as contracts have been executed.
Over the last few years EID has been placing increasing emphasis on higher margin export markets as budget constraints in Portugal have hit home. EID’s offerings have proved to be highly attractive in export markets compared to some of the more major suppliers like Harris, Rohde and Schwarz and Thales, combining a high level of functionality and technical sophistication with a low cost base and competitive pricing. At present domestic activity is focused on longer-term support work providing a recurring stream of revenues, although contracts tend to be relatively short and renewed on a regular basis. EID is one of the few capable domestic producers and is thus well positioned to gain from any increase in new equipment programmes. While highly volatile, we believe the domestic market accounts for around 20%-40% of EID sales.
In addition to adding Portugal as a home market, EID also contributes the strong and growing export market relationships it has developed, both to other NATO Europe countries and further afield, for example Egypt and Indonesia. For example, over 130 warships now utilise EID’s communications equipment, which can be provided for both new build and upgrade projects. This global presence is expected to stimulate new export opportunities for Cohort’s existing businesses.
Sensitivities
■
UK defence budget, Brexit and SDSR: The 2015 Strategic Defence and Security Review (SDSR) and subsequent developments have enhanced visibility for many of Cohort’s key capabilities. For example, spending on submarine programmes show sustained growth through the current ten-year MOD budget plan despite more modest overall procurement growth. Sole source contract margin restrictions are also relevant although this developing topic is not seen as unduly penalising companies such as Cohort where most contracts are won in competition. As defence policy has always remained sovereign under the EU, Brexit is not expected to dramatically alter Cohort’s position. It has little existing direct UK activity to Europe and EID adds direct access. Most of Cohort’s non-EID European business relates to NATO activity.
■
Export contract visibility and timing: Export contracts tend to offer higher margin sales and thus can be material in terms of expectations. However, timing of contract award is difficult to predict, so we take a cautious view when forecasting long-term export wins.
■
Rebids, follow-ons and renewals: While there is always a risk with rebids, we note that SCS has held contracts to support the Joint Forces Command and its predecessors continuously since 1996, successfully rebidding in competition multiple times. Follow on development contracts and renewals also carry levels of uncertainty, although Cohort’s project involvements tend to be stable, long term and operationally committed.
■
Acquisition performance: Management’s ability to successfully integrate and deliver acquisition business cases including potential synergies could affect results. Cohort maintains a rigorous acquisition, management and review process to ensure successful execution.
■
FX movements: Until the acquisition of EID the impact of FX exposure was quite limited. EID introduces an element of translational exposure to the €/£ rate, as well as some additional transactional $/€ transactional exposure in export markets.
Valuation
We derive a fair value for Cohort from the simple average of two distinct methodologies; a capped DCF and a peer-based group SOP. This currently implies a fair value of 439p, equivalent to a P/E ratio of 15.1x CY17 EPS, which represents a 41% premium to the current share price and equates to a 9% PER premium to the broader UK Defence sector. We feel that this is supported by the visibility afforded by the order cover, with growth potential derived from further ECS contracts and export opportunities, the timing of which are difficult to predict, as well as the addition of EID.
Capped DCF valuation
We have utilised a capped DCF methodology to value Cohort. The valuation utilises our forecasts cash flows for a period of six years, then assumes zero growth in the terminal value. To reflect the lack of growth, we also normalise capex to depreciation and working capital movements to zero in the terminal cash flow. For Cohort we use a calculated WACC of 7.9% in our base assumption, and this currently returns a value of 453p per share.
Exhibit 12: Capped DCF sensitivity (p/share) analysis for WACC and terminal growth rate
WACC |
6.00% |
6.50% |
7.00% |
7.50% |
8.00% |
8.50% |
9.00% |
9.50% |
10.00% |
Terminal growth rate |
|||||||||
0% |
614 |
562 |
5187 |
480 |
447 |
418 |
392 |
369 |
349 |
1% |
618 |
567 |
522 |
484 |
451 |
421 |
395 |
372 |
351 |
2% |
623 |
571 |
526 |
488 |
454 |
424 |
398 |
374 |
353 |
3% |
628 |
575 |
530 |
491 |
457 |
427 |
401 |
377 |
356 |
Source: Edison Investment Research estimates
For a company such as Cohort where we envisage a continued growth of cash flows due to the strategy, we feel that such a methodology is inherently conservative for a DCF. We show a sensitivity analysis to terminal growth rate and WACC assumptions in exhibit 12 above, with the value closest to our calculated levels highlighted.
Peer group sum of the parts (SOP)
We also continue to analyse Cohort on a sum-of-the-parts basis, identifying the nearest peers for each division and based on a calendar 2017 basis. We feel that this is appropriate due to the nature of the group with standalone divisions. Currently the derived value is 424p per share.
Exhibit 13: Cohort peer group SOP calculation (CY17 basis)
EBITA (CY17) |
Tax rate (%) |
NOPAT (CY17) |
P/E ratio |
Value |
Notes |
|
MASS |
6.3 |
16.0% |
5.3 |
13.5 |
71 |
Average of QinetiQ (14.6x), Ultra (12.4x) and Cobham (13.4x) |
SCS |
1.3 |
16.0% |
1.1 |
13.1 |
14 |
10% discount to QinetiQ (14.6x) |
SEA |
6.0 |
16.0% |
5.0 |
13.5 |
68 |
Average of QinetiQ (14.6x) and Ultra (12.4x) |
MCL |
1.9 |
16.0% |
1.6 |
11.6 |
19 |
10% discount to Ultra (12.4x) and Cobham (13.4x) |
EID |
2.2 |
16.0% |
1.8 |
13.5 |
25 |
Average of QinetiQ (14.6x) and Ultra (12.4x) |
Less Minority interest in EID |
-5 |
20% of EID |
||||
Less Head office costs |
-26 |
Calendarised central costs (12.4x PER) |
||||
EV (£m) |
166 |
|||||
Net cash |
5 |
FY17e net cash after EID and MCL minority purchases |
||||
Equity value (£m) |
170 |
|||||
Shares in issue |
40.2 |
|||||
Implied fair value per share (p) |
|
|
|
|
424 |
|
Source: Bloomberg, Edison Investment Research estimates
Financials
Exhibit 14: Cohort revisions to estimates
Year to April (£m) |
2017e |
% |
2018e |
% |
||
|
Prior |
New |
change |
Prior |
New |
change |
MASS |
34.1 |
34.1 |
0.0 |
37.1 |
37.1 |
0.0 |
SCS |
17.5 |
17.5 |
0.0 |
17.5 |
17.5 |
0.0 |
SEA |
50.0 |
50.0 |
0.0 |
53.5 |
53.5 |
0.0 |
MCL |
17.0 |
17.0 |
0.0 |
18.0 |
18.0 |
0.0 |
EID |
13.1 |
13.1 |
0.0 |
17.3 |
17.3 |
0.0 |
Total Group |
131.7 |
131.7 |
0.0 |
143.4 |
143.4 |
0.0 |
|
|
|
|
|
|
|
EBITDA |
15.1 |
15.5 |
3.1 |
16.4 |
17.0 |
3.4 |
|
|
|
|
|
|
|
MASS |
6.1 |
6.1 |
0.0 |
6.3 |
6.3 |
0.0 |
SCS |
1.3 |
1.3 |
0.0 |
1.3 |
1.3 |
0.0 |
SEA |
5.7 |
5.7 |
0.0 |
6.2 |
6.2 |
0.0 |
MCL |
1.9 |
1.9 |
0.0 |
2.0 |
2.0 |
0.0 |
EID |
1.7 |
1.7 |
0.0 |
2.4 |
2.4 |
0.0 |
HQ Other and intersegment |
-2.5 |
-2.5 |
0.0 |
-2.5 |
-2.5 |
0.0 |
Adjusted OPBIT (pre PPA amortisation) |
14.3 |
14.3 |
0.0 |
15.6 |
15.6 |
0.0 |
|
|
|
|
|
|
|
Underlying PTP |
14.3 |
14.3 |
0.3 |
15.6 |
15.7 |
0.3 |
|
|
|
|
|
|
|
EPS - underlying continuing (p) |
26.5 |
25.9 |
2.8 |
31.3 |
31.6 |
0.9 |
DPS (p) |
7.0 |
7.0 |
0.0 |
8.0 |
8.0 |
0.0 |
Net cash/(debt) |
4.6 |
5.2 |
17.2 |
12.1 |
12.5 |
7.4 |
Source: Edison Investment Research estimates
Our estimates for Cohort remain unchanged at the revenue and adjusted operating profit level. However, we have slightly adjusted both our depreciation and acquired intangible amortisation levels to more appropriately reflect the changes in the structure of the group. This leads to a slight uplift in EBITDA. We have also assumed a modest net interest inflow as the completion of the EID acquisition is expected to leave the company with significant net cash balances. EID is to be 100% consolidated, with an initial minority of 43% expected to fall to 20% by the half year as the increased stake is purchased. The purchase price allocation has yet to be published by management, but we have assumed a significant intangible recognition of £7.5m relating principally to contracts acquired and an aggressive amortisation period of five years.
We continue to assume the outstanding 50% MCL minority will be bought in by the end of the year, and that the EID stake will be increased to 80% from the initial 57% by the end of November. The resultant adjustments at the earnings level, including the aforementioned PPA amortisation changes, combined with a lower average share count due to an increase in treasury stock results in a modest adjustment to our basic adjusted EPS estimates for FY17 and FY18.
A lower tax charge of around 16% is expected in FY17, and long term changes to the R&D tax treatment may provide further favourable reductions to the rate in future years. FY16 adjusted EPS of 27.18p included one-off tax credits amounting to around 2.20p per share. Thus our revised EPS forecast for FY17 represents growth of just under 9%. Our view that significant EPS growth should resume in FY18 remains unchanged.
Strong cash flows funding expansion
We expect the group to continue to generate strong free cash flows enhanced by EID. The better than expected working capital performance in FY16 was largely due to further receipts from the ECS programme at SEA, which left group net funds standing at £19.8m. As noted at the prelims and in the recent AGM statement, an outflow is expected in FY17 as the contracts continue to execute. New export order advance payments and contract milestone payments could favourably improve working capital performance.
The payments for 80% of EID and the c50% MCL minority are expected to consume £12.5m. The company also expects to increase its own research and development spend to around £2m in the current year excluding EID, which compares to £1.4m in FY16. This complements a high level of customer funding received in MASS and SEA and is evidence of the group investing for organic growth through new product opportunities. Despite some increase in dividends, tax and capex, we still expect the company to retain net cash balances in excess of £5m at the end of FY17.
We expect cash flow to improve significantly in FY18, and Cohort has borrowing facilities totalling £25m that should support further M&A when the opportunities arise.
Exhibit 15: Financial summary
£m |
2013 |
2014 |
2015 |
2016 |
2017e |
2018e |
||
Year end 30 April |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
PROFIT & LOSS |
||||||||
Revenue |
|
|
70.9 |
71.6 |
99.9 |
112.6 |
131.7 |
143.4 |
Cost of Sales |
(47.6) |
(47.8) |
(70.0) |
(79.1) |
(92.5) |
(100.7) |
||
Gross Profit |
23.2 |
23.7 |
30.0 |
33.5 |
39.2 |
42.7 |
||
EBITDA |
|
|
7.9 |
8.8 |
11.0 |
13.0 |
15.5 |
17.0 |
Operating Profit (before amort. and except.) |
7.3 |
8.2 |
10.1 |
11.9 |
14.3 |
15.6 |
||
Intangible Amortisation |
(0.7) |
(0.1) |
(3.6) |
(6.4) |
(7.0) |
(6.7) |
||
Exceptionals |
1.8 |
(1.5) |
(0.6) |
(0.3) |
0.0 |
0.0 |
||
Other |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Operating Profit |
8.4 |
6.6 |
5.9 |
5.2 |
7.2 |
8.9 |
||
Net Interest |
0.1 |
0.1 |
0.1 |
0.1 |
0.0 |
0.0 |
||
Profit Before Tax (norm) |
|
|
7.5 |
8.3 |
10.2 |
12.0 |
14.3 |
15.7 |
Profit Before Tax (FRS 3) |
|
|
8.5 |
6.7 |
5.9 |
5.3 |
7.3 |
9.0 |
Tax |
(0.2) |
(0.8) |
(0.7) |
0.1 |
(1.6) |
(1.5) |
||
Profit After Tax (norm) |
7.3 |
7.7 |
8.9 |
11.2 |
12.0 |
13.2 |
||
Profit After Tax (FRS 3) |
8.3 |
5.9 |
5.2 |
5.4 |
5.7 |
7.5 |
||
Average Number of Shares Outstanding (m) |
40.2 |
40.0 |
40.1 |
40.6 |
40.2 |
40.2 |
||
EPS - normalised (p) |
|
|
18.2 |
19.1 |
20.5 |
27.2 |
25.9 |
31.6 |
EPS - normalised and fully diluted (p) |
|
17.9 |
18.7 |
20.0 |
26.7 |
25.4 |
31.0 |
|
EPS - (IFRS) (p) |
|
|
20.8 |
14.7 |
11.2 |
12.7 |
10.2 |
17.5 |
Dividend per share (p) |
3.5 |
4.2 |
5.0 |
6.0 |
7.0 |
8.0 |
||
Gross Margin (%) |
32.8 |
33.1 |
30.0 |
29.8 |
29.8 |
29.8 |
||
EBITDA Margin (%) |
11.2 |
12.3 |
11.0 |
11.5 |
11.8 |
11.9 |
||
Operating Margin (before GW and except.) (%) |
10.4 |
11.4 |
10.1 |
10.6 |
10.8 |
10.9 |
||
BALANCE SHEET |
||||||||
Fixed Assets |
|
|
38.4 |
37.9 |
66.2 |
59.7 |
66.7 |
61.5 |
Intangible Assets |
31.5 |
29.4 |
55.8 |
49.5 |
49.9 |
43.3 |
||
Tangible Assets |
6.9 |
8.5 |
10.3 |
10.2 |
16.8 |
18.2 |
||
Investments |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Current Assets |
|
|
35.8 |
39.1 |
40.3 |
54.0 |
41.6 |
54.8 |
Stocks |
0.2 |
0.3 |
1.1 |
2.0 |
2.5 |
2.8 |
||
Debtors |
16.9 |
18.2 |
19.4 |
27.3 |
31.9 |
34.7 |
||
Cash |
16.4 |
16.3 |
19.7 |
23.1 |
5.6 |
15.6 |
||
Other |
2.2 |
4.3 |
0.1 |
1.6 |
1.7 |
1.8 |
||
Current Liabilities |
|
|
(14.4) |
(14.2) |
(26.8) |
(40.1) |
(34.4) |
(35.3) |
Creditors |
(14.4) |
(14.2) |
(26.8) |
(36.8) |
(34.4) |
(35.3) |
||
Short term borrowings |
0.0 |
0.0 |
(0.0) |
(3.3) |
0.0 |
0.0 |
||
Long Term Liabilities |
|
|
(0.7) |
(0.6) |
(16.9) |
(2.7) |
(3.1) |
(5.8) |
Long term borrowings |
0.0 |
0.0 |
(0.0) |
(0.0) |
(0.4) |
(3.1) |
||
Other long term liabilities |
(0.7) |
(0.6) |
(16.8) |
(2.7) |
(2.7) |
(2.7) |
||
Net Assets |
|
|
59.0 |
62.2 |
62.8 |
70.8 |
70.9 |
75.2 |
CASH FLOW |
||||||||
Operating Cash Flow |
|
|
5.2 |
2.6 |
20.5 |
8.5 |
5.4 |
15.5 |
Net Interest |
0.1 |
0.1 |
0.1 |
0.1 |
0.0 |
0.0 |
||
Tax |
(1.1) |
0.0 |
(1.7) |
(1.8) |
(2.3) |
(2.5) |
||
Capex |
(0.3) |
(2.3) |
(1.1) |
(1.0) |
(2.6) |
(2.8) |
||
Acquisitions/disposals |
0.0 |
2.5 |
(13.5) |
(0.7) |
(12.5) |
0.0 |
||
Financing |
(0.4) |
(1.5) |
0.8 |
(3.2) |
0.0 |
0.0 |
||
Dividends |
(1.2) |
(1.5) |
(1.8) |
(2.2) |
(2.5) |
(2.9) |
||
Net Cash Flow |
2.3 |
(0.1) |
3.3 |
(0.3) |
(14.6) |
7.3 |
||
Opening net debt/(cash) |
|
|
(14.1) |
(16.4) |
(16.3) |
(19.7) |
(19.8) |
(5.2) |
HP finance leases initiated |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other |
0.0 |
(0.0) |
(0.0) |
0.5 |
0.0 |
0.0 |
||
Closing net debt/(cash) |
|
|
(16.4) |
(16.3) |
(19.7) |
(19.8) |
(5.2) |
(12.5) |
Source: Company reports, Edison Investment Research estimates
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|